scispace - formally typeset
C

Catherine Tuleu

Researcher at University College London

Publications -  121
Citations -  3359

Catherine Tuleu is an academic researcher from University College London. The author has contributed to research in topics: Taste & Taste aversion. The author has an hindex of 28, co-authored 115 publications receiving 2711 citations. Previous affiliations of Catherine Tuleu include University of London.

Papers
More filters
Journal ArticleDOI

Paediatric formulations--getting to the heart of the problem.

TL;DR: In this paper, the authors looked at a list of medicines commonly prescribed for children with cardiovascular conditions in an English specialist paediatric hospital and classified them according to licensed status and available formulations.
Journal ArticleDOI

Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.

TL;DR: The aim of this review is to provide an overview of different approaches to taste masking APIs in paediatric oral dosage forms, with a focus on the tolerability of excipients used.
Journal ArticleDOI

Minitablets: New Modality to Deliver Medicines to Preschool-Aged Children

TL;DR: This study demonstrated the potential to use minitablets for the treatment of preschool-aged children and suggests that minitablet can be used as a potential new formulation for children in this age range.
Journal ArticleDOI

Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms.

TL;DR: Harmonization of endeavors from regulators, industry and academia by sharing learning associated with data obtained from pediatric investigation plans, product development pathways and scientific projects would be the way forward to speed up bench-to-market age appropriate formulation development.
Journal ArticleDOI

Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations.

TL;DR: A better understanding of the acceptability of existing formulations highlights opportunities for the development of new and more acceptable medicines and facilitates safe and effective prescribing for the young and older populations.